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ABSTRACT
TANGO1 (transport and Golgi organization-1 homolog) encodes a transmembrane protein, which is located at endoplasmic reticulum
(ER) exit sites where it binds bulky cargo, such as collagens, in the lumen and recruits membranes from the ER-Golgi intermediate
compartment (ERGIC) to create an export route for cargo secretion. Mice lacking Mia3 (murine TANGO1 orthologue) show defective
secretion of numerous procollagens and lead to neonatal lethality due to insufficient bone mineralization. Recently, aberrant expres-
sion of truncated TANGO1 in humans has been shown to cause a mild-to-moderate severe collagenopathy associated with dentino-
genesis imperfecta, short stature, skeletal abnormalities, diabetes mellitus, and mild intellectual disability. We now show for the first
time that complete loss of TANGO1 results in human embryonic lethality with near-total bone loss and phenocopies the situation of
Mia3−/− mice. Whole-exome sequencing on genomic DNA (gDNA) of an aborted fetus of Indian descent revealed a homozygous
4-base pair (4-bp) deletion in TANGO1 that is heterozygously present in both healthy parents. Parental fibroblast studies showed
decreased TANGO1mRNA expression and protein levels. Type I collagen secretion and extracellular matrix organization were normal,
supporting a threshold model for clinical phenotype development. As such, our report broadens the phenotypic and mutational
spectrum of TANGO1-related collagenopathies, and underscores the crucial role of TANGO1 for normal bone development, of which
deficiency results in a severe-to-lethal form of osteochondrodysplasia. © 2021 American Society for Bone and Mineral Research ©
2020 The Authors. JBMR Plus published by Wiley Periodicals LLC. on behalf of American Society for Bone and Mineral Research.
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1. Introduction
The identification of the transport and Golgi organization-1homolog (TANGO1) protein as a key player between cyto-
plasmic coat protein complex (COP) II coats and cargoes, kindled
the interest in the pathway by which cells export bulky secretory
cargoes such as collagens.(1–3) Its encoding gene TANGO1, located
at chromosome 1q41, comprises 8142 base pairs (bp) which code
for two distinct alternative spliced isoforms, full-length TANGO1
and TANGO1-short. Full-length TANGO1 contains an N-terminal
signal sequence, followed by a luminal SH3-like domain, two
putative transmembrane domains, coiled-coil domains, and a
cytoplasmic proline-rich domain (PRD), respectively (Fig. 1A).(1)
TANGO1-short lacks the luminal portion and has been shown to
back up the function of full length TANGO1 in collagen export,
and vice versa.(4) The interaction of TANGO1 with collagens
requires binding of the SH3-like domain to the collagen-specific
chaperone HSP47,(1,5) whereas the PRD domain of TANGO1 inter-
acts with endoplasmic reticulum (ER) exit sites (ERES), and the
COPII components Sec23/Sec24.(1) TANGO1 has also been dem-
onstrated to bind cTAGE5, another ERES-resident protein, which
recruits Sec12 and in turn enrolls more COPII coats.(1,6,7) As such,
TANGO1 has at least three major functions: it recruits and binds
COPII coats; it engages ER–Golgi intermediate compartment
53 (ERGIC-53)–containing membranes; and it binds HSP47, which
then collects procollagens.(8–10) A schemeof TANGO1 functions in
creating a route for procollagen export is shown in Fig. 2.
Mice lacking Mia3 (murine TANGO1 orthologue) display a
chondrodysplasia that becomes already apparent as early as
15.5 to 16.5 days post-coitum (dpc) and causes dwarfing of the
fetus with shortening of the snout and limbs, fragility of multiple
tissues and the skin, and peripheral edema, all leading to perina-
tal lethality with complete absence of the mature ossified skele-
ton. Further analysis showed defective secretion of numerous
collagens (including collagens I, II, III, IV, VII, and IX) from chon-
drocytes, fibroblasts, and endothelial and mural cells.(11) In this
report we present a consanguineous Indian family, in whom
the proband is a fetus presenting with early lethality and almost
complete absence of bone formation. Whole-exome sequencing
(WES) analysis revealed a novel homozygous frameshift variant,
generating a premature termination codon and predicted com-
plete absence of the TANGO1 protein. Herewith, we underscore
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the previous observation that TANGO1 plays a unique role in
normal embryonal skeletogenesis and add TANGO1 as a novel
gene to the group of human lethal osteochondrodysplasias.
2. Materials and Methods
2.1 Study oversight and sequencing
The study was conducted in accordance with the Declaration of
Helsinki, and informed consent was obtained from the parents
and the age/sex matched control individuals. WES was per-
formed on genomic DNA (gDNA) from the proband using the
Human All Exon V6 enrichment kit (Agilent Technologies, Santa
Clara, CA, USA), followed by paired-end sequencing (2 × 150
bp) on a HiSeq3000 sequencer (Illumina, San Diego, CA, USA).
Variant calling and analysis were performed using our in-house
developed variant annotation and querying platform “Seq-
Plorer” (unpublished) and ExomeDepth(12) was used to call rare
copy number variants (CNVs). Variants were sorted as described
in the text and confirmed by bidirectional Sanger sequencing
using the BigDye® Terminator Cycle Sequencing kit and the
ABI 3730XL DNA Analyzer (Applied Biosystems, Foster City, CA,
USA). Nucleotide numbering reflects cDNA numbering, with +1
corresponding to the A of the ATG translation initiation codon
in the TANGO1 reference sequence, amino acid residues are
numbered from the first methionine residue of the protein
Fig. 1. Structure of the TANGO1 gene and protein, clinical findings of the Indian consanguineous family, and overview of the exome filter strategy. (A) The
TANGO1 gene consists of 28 exons (8142 bp) and comprises 49.91 kb on chromosome 1. Full-length TANGO1 protein consists of 1907 amino acids, and
contains luminal, transmembrane, and cytosolic domains. TANGO1-short lacks the luminal portion and contains the domains shown in color gradient. The
earlier identified pathogenic variant p.(Arg1207=) and our variant p.(Leu924Serfs*) are highlighted. (B) Pedigree of the Indian family with reported con-
sanguinity. The proband (IV:4) is indicated with an arrow, asterisks denote family members available for molecular testing, the parents are obligate carriers
of the identified variant. (C) Anterior–posterior radiographs from IV:4 at 13 weeks of gestation reveal short and bowed extremities and a remarkable
undermineralization throughout the whole body. (D) WES generated 32332 variants in the proband that differed from the consensus genomic sequence
(GRCh37/hg19), and ExomeDepth called 229 rare CNVs (93 duplications and 136 deletions). No variant or CNV was retained when filtering the whole
exome dataset for the known OI genes (left), 6 candidates resulted from retaining variants that correspond to the combination of 6 filter settings (right).
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reference sequence (GRCh38.p13, NM_198551.4). Variant
nomenclature and classification is according to the HGVS and
ACMG guidelines,(13) and the variant was submitted to the Muta-
lyzer server (https://mutalyzer.nl) (output file in the Supplemen-
tary Material).
We used the GeneMatcher server (https://genematcher.org)
in order to search for other TANGO1-families.
2.2 Cell culture
Skin biopsies from the parents and age-sex matched controls
were explanted and fibroblast cultures were grown at 37C with
5% CO2 in complete DMEM (Gibco, Thermo Fisher Scientific, Wal-
tham, MA, USA) supplemented with 10% fetal bovine serum
(Biochrom AG, Berlin, Germany), 1% Penicillin/Streptomycin
(Gibco), 1% non-essential amino acids (Gibco) and 0.1% Fungi-
zone (Gibco).
2.3 Quantitative real-time PCR
Total RNA was extracted in triplicate from cultured dermal fibro-
blasts with the RNeasy Kit (QIAGEN, Hilden, Germany), and cDNA
was synthesized with the iScript cDNA Synthesis Kit (Bio-Rad
Laboratories, Hercules, CA, USA). Primer sequences are listed in
Supplementary Table S1 (Integrated DNA Technologies, Coral-
ville, IA, USA). For each cDNA sample, RT-qPCR reactions were
prepared with the addition of SsoAdvanced™ Universal SYBR®
Green Supermix (Bio-Rad Laboratories, Hercules, CA, USA), and
were subsequently run in duplicate on a Roche LightCycler
480 System (Roche Diagnostics, Mannheim, Germany). Data
were analyzed with qbase+ software (version 3.0; Biogazelle,
Ghent, Belgium), and expression was normalized to the refer-
ence genes HPRT1, RPL13A, and YWHAZ.
2.4 Immunoblotting
For immunoblotting of TANGO1, HSP47, SEC23A, and SEC24D,
protein lysates were prepared from cultured fibroblasts using a
50mM Tris–HCL buffer (pH 7.4, 150mM NaCl, 1mM ethylenedia-
minetetraacetic acid, 1% Triton X-100) with protease inhibitor
cocktail (Roche, Basel, Switzerland). Cell extracts were scraped,
collected and centrifuged at 18,400 g for 15 min at 4C, and
the supernatant was subsequently subjected to SDS-PAGE
Fig. 2. Function of TANGO1 in procollagen packaging and transport at ERES. Newly synthesized proteins exit the ER via coat protein complex II (COPII)
vesicles, but procollagens form prefibrils that are too large to fit into typical COPII vesicles.(8,22,23) cTAGE5 first binds the ER-membrane protein Sec12
and concentrates it to the ERES. Procollagen is subsequently guided to ERES when TANGO1 binds HSP47 through its ER SH3-like luminal domain. TANGO1
and cTAGE5 bind to the COPII inner coat components Sec23 and Sec24 and recruit the NRZ tethering complex (NBAS/RINT1/ZW10), which in turn recruits
ERGIC membranes to the ERES. TANGO1/cTAGE5 finally assembles the fusion machinery SLY1 and syntaxin18 that drives incorporation of ERGIC mem-
branes into ERES. The transmembrane helices of TANGO1 prevent the miscibility of ERGIC and ERES membranes while allowing the transfer of collagen
from the lumen of the ER to the ERGIC membranes via a tunnel.(5,8,22) Proteins are shown by symbols as defined in the figure legend, all different domains
of TANGO1 are shown and the SH3-like collagen interacting site is highlighted with a dotted line.
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(3–8% Tris-Acetate gels for TANGO1, SEC23A, and SEC24D,
4–12% Bis-Tris gels for HSP47) under reducing conditions
(6.25% 1Mdithiothreitol) (NP0335BOX; Life Technologies Europe,
Merelbeke, Belgium). Proteins were blotted to a nitrocellulose
membrane (3 hours wet blotting for TANGO1; dry blotting [iBlot
2 Dry Blotting System; Thermo Fisher Scientific, Waltham, MA,
USA] for HSP47, SEC23A, and SEC24D). Membranes were blocked
in 5% BSA (TANGO1), 2% ECL Blocking Agent (GE Healthcare, Chi-
cago, IL, USA) (HSP47, SEC23A, and β-tubulin), or 5% dry milk
(SEC24D), incubated overnight with primary antibodies against
TANGO1 (1/1000; HPA055922; Sigma-Aldrich, St. Louis, MO,
USA), HSP47 (1/1500; ab54874; Abcam, Cambridge, UK), SEC23A
(1/500; ab179811; Abcam), SEC24D (1/1500; ab191566; Abcam),
or β-tubulin (1/1500; ab6046; Abcam), and subsequently incu-
bated with horseradish peroxidase–conjugated secondary anti-
body (1/1500; 7074S and 7076S; Cell Signaling Technologies,
Leiden, The Netherlands). Membranes were scanned with an
Amersham Imager 680 System (GE Healthcare, Chicago, IL,
USA), quantitation was achieved using ImageJ software (NIH,
Bethesda, MD, USA; https://imagej.nih.gov/ij/) and normalized
to the amount of β-tubulin. Graphs display data points normal-
ized to control values.
2.5 Immunocytochemistry
In order to study the type I collagen extracellularmatrix organiza-
tion, 60,000 fibroblasts cells were seeded in eight-well Nunc Lab-
Tek chamber slides (Thermo Fisher Scientific Scientific, Waltham,
MA, USA), grown in medium (composition as described above)
supplemented with 25 μg/mL ascorbic acid. After 48 hours
(2 days) or 120 hours (5 days), cells were fixed with 4% (wt/vol)
paraformaldehyde (Sigma-Aldrich), permeabilized with Triton
X-100 (0.5% (vol/vol) in PBS) and blocked with bovine serum
albumin (BSA; 5% (wt/vol) in PBS). Cells were next incubatedwith
the primary type I collagen (1/100; AB758; Merck Millipore, Bur-
lington, MA, USA) and secondary antibodies (AlexaFluor488 con-
jugated anti-goat (1:1500; Molecular Probes, Life Technologies,
Carlsbad, CA, USA) diluted in 2% BSA/PBS. Nuclei were counter-
stained with DAPI (40-60-diamidino-2-phenylinodole hydro-
xychloride; Vector Laboratories, Burlingame, CA, USA). Stained
preparations were analyzed using the Axio Observer.Z1 fluores-
cence microscope (Carl Zeiss Microscopy, Thornwood, NY,
USA). Images were captured and processed with the Zen pro
software (Carl Zeiss).
2.6 Collagen secretion assays
The pulse-chase secretion kinetics studies for type I collagen
were performed as described.(14,15) In brief, fibroblasts were
seeded and grown for 24 hours in medium (composition as
described in section 2.2 Cell culture) supplemented with 25 μg/
mL ascorbic acid, labeled for 4 hours with [14C]-proline and
chased with fresh medium containing 2mM cold proline.
Medium and cell layer procollagens were harvested at the indi-
cated times and pepsin-digested. Two wells for each assay were
left unlabeled to provide an accurate cell count for normalization
between cell lines. Normalized samples were run on 6% SDS-
PAGE gels and visualized by autoradiography.
2.7 Statistical analysis
Statistical analysis was performed using GraphPad Prism 8.3.1
software (GraphPad Software, Inc., La Jolla, CA, USA). The RT-qPCR
and immunoblotting results are expressed as mean ± standard
error of the mean (SE) from two or three independent experi-
ments, respectively, and the statistical significance was deter-
mined by performing one-way analysis of variance followed by
Bonferroni’s test for multiple comparisons (see figure legends).
3. Results
3.1 Clinical phenotype
We report an Indian family with third degree consanguinity
(Fig. 1B), with a history of three induced termination-of-
pregnancy because of clinical suspicion of lethal osteogenesis
imperfecta (OI) and one full-term pregnancy. The proband
(IV:4) was a fetus who on ultrasound at 13 weeks of gestation
showed tetramicromelia, increased nuchal translucency thick-
ness of 4.7 mm, absence of the nasal bone, compressibility of
the skull, significant shortening of the long bone segments,
and an impressive undermineralization throughout the whole
body. On X-ray, only improperly formed bones in the region of
the femur and tibia could be noticed at this point (Fig. 1C).
The first pregnancy of the couple was terminated at
13 weeks of gestational age. The fetus (IV:1) presented with
short long bones in both upper and lower limbs, fetal hydrops,
nuchal translucency of 4.1 mm, a normal amniotic fluid index,
and no nasal bone. Ultrasound measurements were consistent
with the clinical diagnosis of lethal OI. Patient IV:2 was a girl,
born after a full-term pregnancy, with normal ultrasound during
pregnancy, which was complicated by fetal hydrops. Birth
weight was 2.75 kg. She suffered from generalized edema and
abdominal distension (hepatomegaly). She started vomiting
after 1 month of age and had clay-colored stools (starting at
1.5 months old). She passed away at 3 months of age, e causa
ignota (presumed biliary atresia). No abnormal bone phenotype
for this child was reported. The third pregnancy was also termi-
nated at 13 weeks of gestation after ultrasound measurements
of the fetus (IV:3), which revealed an increased nuchal translu-
cency thickness of 4.6 mm and fetal hydrops, but no obvious
skeletal abnormalities were seen. Both father (III:1) and mother
(III:2) have normal karyotyping patterns and do not present with
any clinical sign of OI. Other family members were not available
for clinical assessment.
3.2 WES
We performedWES for the proband (IV:4) and analyzed the data-
set using an in-house–developed platform and the ExomeDepth
copy number variant (CNV) calling algorithm.(12) In view of the
clinical history of this family, we first analyzed the WES dataset
for the presence of (likely) pathogenic variants or CNVs in known
OI genes (BMP1, CCDC134, COL1A1, COL1A2, CREB3L1, CRTAP,
FKBP10, IFITM5,MESD,MBTPS2, P3H1, PLOD2, PPIB, SERPINF1, SER-
PINH1, SP7, SPARC, TAPT1, TMEM38B, and WNT1) (Fig. 1D). No
(likely) pathogenic variants or CNVs were detected. Subse-
quently, theWES dataset was analyzed applying the following fil-
ter settings: (i) homozygous variants (in view of the reported
consanguinity within this family) with a medium and high
impact, (ii) variants with an allele frequency of 0.001 or less (for
the Ensembl Variant Effect Predictor(16) and other population
databases including Genome Aggregation Database [gnomAD]);
(iii) variants that are present less than 3 times in our in-house
exome population; (iv) variants with a quality score of 20 or
higher; (v) variants that were covered more than 10×; and
(vi) variants that were not linked to an rs-number. This resulted
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in six candidate variants (Fig. 1D, Table 1). Literature searches,
combined with the MARRVEL tool, prompted us to reject the var-
iants in MCRIP1, MROH8, NUTM2G, MUC19, and KRTAP9-1 as
reasonable candidates. MCRIP1 encodes Mapk-regulated
corepressor-interacting protein 1, which is involved in the regula-
tion of epithelial-mesenchymal transition, and is not yet linked to
human disease. Genomewide association studies (GWASs) previ-
ously linkedMROH8 (Maestro heat-like repeat-containing protein
familymember 8) to Alzheimer’s disease, whereas the exact func-
tion of NUTM2G is not known. MUC19, which encodes Mucin-19,
is linked with inflammatory response, hematopoietic progenitor
and salivary gland cell differentiation through mice studies, and
is associated with TN Polyagglutination Syndrome and colorectal
cancer. KRTPAP9-1 (Keratin-associated protein 9-1) is a known
matrix protein which functions in keratinization (Table 1). The
most interesting candidate variant was a homozygous out-of-
frame 4-bp deletion (c.2770_2773del, p.(Leu924Serfs*)) in exon
4 of the TANGO1 gene, which was confirmed by Sanger
sequencing. Segregation analysis showed that both parents are
heterozygote carriers of the TANGO1 variant (Fig. 1B). In order
to identify additional cases harboring TANGO1-variants, we sub-
mitted this gene to the GeneMatcher server. Unfortunately, no
additional case could be found. Interestingly, previously
described Mia3-null mice showed neonatal lethality due to
severely compromised chondrocytematuration and boneminer-
alization, leading to almost complete lack of bone formation.(11)
The striking similarity in absence of bone formation in both the
Mia3-null mice and the fetus described in this study and the
importance of TANGO1 in collagen trafficking prompted us to
perform further functional studies.
3.3 Fibroblast studies
Because no fibroblasts were available from the proband, func-
tional studies were conducted on parental fibroblasts in order
to gain insights into the pathophysiology underlying the
Table 1. Candidate Variants/Genes From Exome Sorting
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SeqPlorer and MARRVEL (http://www.marrvel.org/) were used to sort the variants frommost likely pathogenic (top) to probably pathogenic (bottom)
and to investigate the functional annotation of these genes and rare variants, respectively. The variant in the TANGO1 gene is listed as the best candi-
date.MARRVEL = Model Organism Aggregated Resources for Rare Variant Exploration.
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TANGO1 variant. The identified frameshift variant is located in
the luminal N-terminal part of the gene (Fig. 1A). Introduction
of a premature termination codon is predicted to lead to
nonsense-mediated decay (NMD), causing loss of both the lumi-
nal and cytosolic part of the protein and thus loss of expression
of the full-length TANGO1. To investigate this, we first designed
specific RT-qPCR assays to measure mRNA expression levels for
both the luminal (TANGO1_lum) and the cytosolic (TANGO1_cyt)
proportion, respectively. Expression levels of TANGO1_cyt and
TANGO1_lum in both parental RNA samples (III:1 and III:2) were
halved when compared to age/sex matched controls (C1, C2,
C3, and C4) (Fig. 3A), pointing toward unstable mutant mRNA
molecules for both luminal and cytosolic portions of TANGO1
and thus loss of expression of the mutant allele. Immunoblotting
with an antibody against the full length TANGO1 protein (recog-
nizing amino acids 422–509, located in the luminal part
upstream of the identified frameshift), revealed that full-length
TANGO1 protein levels were reduced to about 50% in both het-
erozygous parents (III:1 and III:2), thereby confirming NMD of the
mutant TANGO1 allele (Fig. 3B).
Next, we investigated whether decreased TANGO1 levels
could affect the normal functioning of TANGO1 in collagen
secretion. Therefore, we first focused on key components in
TANGO1 trafficking at ERES: the “upstream” HSP47 and “down-
stream” SEC23A/SEC24D components (Fig. 2). The collagen-
specific chaperone HSP47 (encoded by SERPINH1) was previously
shown to bind to the SH3-like domain of TANGO1.(5) Both tran-
scriptional (RT-qPCR) and translational (immunoblotting) levels
of SERPINH1 (Fig. 3A,B) were normal in heterozygous carriers.
However, the downstream targets SEC23A and SEC24D tended
to be (slightly) upregulated at both mRNA and protein levels
(Fig. 3A,B).
To investigate a possible effect on large cargo trafficking, we
assessed collagen organization and secretion. First, immunocy-
tochemistry for type I collagen, after 2 or 5 days of ascorbic acid
stimulation, revealed that type I collagen extracellular matrix
organization was normal in the heterozygous parents (Fig. 3C,
D). In addition, a pulse-chase secretion assay showed normal
secretion kinetics for type I collagen in the heterozygous parents
compared to age/sex matched control individuals (Fig. 3E).
4. Discussion
In 2011, Wilson and colleagues(11) demonstrated that mice defi-
cient for Mia3 present with a chondrodysplasia characterized by
severe dwarfism and neonatal lethality, which was caused by
impaired chondrocyte maturation and lack of bonemineralization.
The delay in mineralization in Mia3−/− pups was already apparent
as early as 13.5 dpc, with an almost complete lack of calcium
deposits at 15.5 dpc when normal primary mineralization is initi-
ated. In wild-type mice, primary ossification is accompanied by
invasion of osteoblasts, necessary for secondary mineralization,
and is characterized by expression of matrix metalloproteinase
9 (Mmp9), which primes the mineralized matrix for vascular inva-
sion. However, in mutantMia3−/− pups, the expression of the lat-
ter was strongly reduced. Furthermore, Wilson and colleagues(11)
also demonstrated that in the dwarfed Mia3−/− mutants at 14.5
dpc no osteopontin-positive osteoblasts were present, leading
to absence of osteoblast-derived type I collagen and insulin-like
growth factor-binding protein (Igfbp6) in the perichondrium,
eventually resulting in absence of ossified tissue at 18.5 dpc and
thus also absence of secondary mineralization. These findings
were also corroborated by histological analyses revealing defects
in chondrocytic ECM deposition, absence of mineralized bone
collar and well-defined trabeculae in Mia3−/− pups. Although
major chondrocyte maturation signaling axes, such as the Indian
hedgehog and patched pathway, were preserved, studies on pri-
mary mouse embryonic fibroblasts revealed that timely expres-
sion of type II and type X collagen is dependent on Mia3, as is
the case for the transit andmaturation of several other collagens.
Thereby, Wilson and colleagues(11) elegantly demonstrated that
the generalized dwarfing of the skeleton of the Mia3 deficient
pups is primarily driven by: the delay and arrest of chondrogenic
maturation; lack of vascular recruitment; and the failure to elabo-
rate a primary ossification center, highlighting the sensitivity of
the chondrogenic/skeletogenic processes to defects in the secre-
tory pathway.
Over the past decade, and in addition to these murine studies,
in vitro exploration in which HeLa(1,4,10) and RDEB/FB/C7 cells(17)
were knocked out for TANGO1 (using siRNAs and clustered reg-
ularly interspaced short palindromic repeats [CRISPR] technol-
ogy) have additionally demonstrated a crucial role of TANGO1
in the context of cargo loading at ERES and collagen secretion.
Recently, Lekszas and colleagues(18) identified a homozygous
synonymous substitution (c.3621A>G, p.(Arg1207=)) in TANGO1,
leading to skipping of exon 8 and the generation of a truncated
TANGO1 protein, which is dispersed in the ER and impairs type I
collagen secretion. Affected patients of this family presented
with dentinogenesis imperfecta in both primary and permanent
dentitions and/or a delayed eruption of the permanent teeth,
various skeletal abnormalities including growth retardation with
proportionate short stature, platyspondyly, scoliosis, osteopenia,
brachydactyly and clinodactyly, primary obesity, insulin-
dependent diabetes mellitus, sensorineural hearing loss, and
mild intellectual disability.(18,19) Some of the patients also pre-
sented with mild retinopathy, early onset periodontitis with pre-
mature tooth loss, hydronephrosis, and microalbuminuria. No
overt bone phenotype was described in the heterozygous car-
riers of this family.
In this study, we describe an Indian family in which the pro-
band (fetus IV:4) presented with early embryonic lethality due
to almost complete lack of bone formation. The fetus is homozy-
gous for an out-of-frame 4-bp deletion in TANGO1. Analogous to
the previously described family,(18) both heterozygous parents of
the family described in this study are healthy and show no overt
Fig. 3. Variant characterization in fibroblasts of heterozygous carriers, compared to age/sexmatched control individuals. (A) RT-qPCR expression analysis
for TANGO1_lum, TANGO1_cyt, SERPINH1, SEC23A, and SEC24D. Data are expressed as mean ± SE, each graph represents the average quantification of
three experiments performed in duplicate (6 data points). (B) Western blot analysis for TANGO1 (full length), HSP47, SEC23A, and SEC24D. Data are
expressed as mean ± SE, each graph represents the average quantification for each experiment. (C,D) Immunocytochemical analysis for extracellular
matrix formation of type I collagen after 2 and 5 days of ascorbic acid stimulation. Nuclei are counterstained with DAPI. Scale bar = 50 μm. (E) Pulse-chase
secretion kinetics of the intracellular (CEL, left panels) and secreted (MED, right panels) type I collagen chains during a 240-min time range. C = control; CEL
= intracellular; MED = secreted.
JBMR® Plus LOSS OF TANGO1 LEADS TO ABSENCE OF BONE MINERALIZATION 7 of 9 n
signs of skeletal involvement. We show that in the heterozygous
parents both transcriptional and translational levels of TANGO1
arehalveddue to the identified TANGO1 variant (Fig. 3A,B). However,
this decrease in TANGO1 does not result in obvious alterations in
type I collagen secretion andorganization in the extracellularmatrix,
and thus further corroborates the earlier hypothesis that TANGO1
haploinsufficiency does not lead to a discernible clinical phenotype,
similar to Mia3+/− mice which do not show an overt phenotype.(18)
Nevertheless, the decreased expression of TANGO1 due to the pres-
ence of the heterozygous 4-bp deletion variant allows to deduce
that homozygosity for this variant would result in complete defi-
ciency of the TANGO1 protein and result in human embryonic
lethality, thereby phenocopying theMia3-nullmice.(11) Interestingly,
although secretion of different collagens, including collagens type I,
II, III, IV, and IX, was disrupted inMia3-null mice, collagen fibrils were
still detected in the ECM, but they were more dispersed and dimin-
ished innumber.(11) As such, our andprevious data(4,11) point toward
a compensational mechanism, whereby secretion of collagens (and
other bulky cargos) is still possible, because the wild-type allele(s) of
(both) full-length and the short isoform of TANGO1 and/or another
ERES resident protein compensate for the loss of expression of the
mutant allele. Notwithstanding, it remains a conundrum why a
trend toward increased RNA and protein levels of the COPII compo-
nents SEC23A and SEC24D is detected in the fibroblasts of the par-
ents (Fig. 3A,B). A possible explanation is that, similar to
TANGO1-short which backs up the function of full length TANGO1
in collagen export,(4) cTAGE5 can compensate for this loss, as it
has been shown to be a coreceptor of TANGO1 at ERES.(6)
An interesting point of discussion is the difference in severity of
thephenotypepresented in patients carrying the homozygous syn-
onymous substitution (c.3621A>G, p.(Arg1207=)) (first family, mild-
to-moderate severe phenotype)(18,19) versus the homozygous
out-of-frame 4-bp deletion (c.2770_2773del, p.(Leu924Serfs*))
described in this report. The homozygous synonymous variant
causes skipping of exon 8 in most products, thereby affecting the
beginning of the cytoplasmic portion of TANGO1 (Fig. 1A, down-
stream of the luminal portion), and resulting in decreased collagen
secretion.(18) In contrast, the homozygous out-of-frame deletion
described here affects the luminal portion of TANGO1, upstream
of the earlier reported synonymous variant, and mimics a full-null
situation as is seen inMia3−/− pups.(11) Our findings thereby further
underscore and add to the previously postulated threshold model,
where the disease manifests in a “mild(er)” form when the ratio of
truncated versus normal protein exceeds a critical level(18), and a
disease severity that is not viable in cases where no functional
TANGO1 is present.
In conclusion, we report the first homozygous frameshift
mutation in TANGO1, predicted to result in complete loss of
TANGO1 in a human fetus with an embryonic lethal osteochon-
drodysplasia. Similar to Mia3 knockout mice, the affected fetus
shows a near-complete absence of bone formation, further sug-
gesting a key role for TANGO1 in early human embryonic devel-
opment, especially in the first stages of bone formation. A more
complete understanding of the role of TANGO1 within the secre-
tory pathway and its link to diabetes will have to come from the
identification of additional patients with defects in TANGO1, and
also by including this gene in prenatal exome strategies.(20,21)
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